Cargando…
Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study
OBJECTIVE: To investigate whether exposure to metformin during the first trimester of pregnancy, for diabetes or other indications, increases the risk of all or specific congenital anomalies. DESIGN: Population based exploratory case-control study using malformed controls. Cases of 29 specific subgr...
Autores principales: | Given, Joanne E, Loane, Maria, Garne, Ester, Addor, Marie-Claude, Bakker, Marian, Bertaut-Nativel, Bénédicte, Gatt, Miriam, Klungsoyr, Kari, Lelong, Nathalie, Morgan, Margery, Neville, Amanda J, Pierini, Anna, Rissmann, Anke, Dolk, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016021/ https://www.ncbi.nlm.nih.gov/pubmed/29941493 http://dx.doi.org/10.1136/bmj.k2477 |
Ejemplares similares
-
Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study
por: Bergman, Jorieke E. H., et al.
Publicado: (2017) -
EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations
por: Given, Joanne E., et al.
Publicado: (2016) -
Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies
por: Dolk, Helen, et al.
Publicado: (2016) -
Trends in congenital anomalies in Europe from 1980 to 2012
por: Morris, Joan K., et al.
Publicado: (2018) -
EUROlinkCAT protocol for a European population-based data linkage study investigating the survival, morbidity and education of children with congenital anomalies
por: Morris, Joan K, et al.
Publicado: (2021)